Position in ABBV
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$112,353,811
-$9,240,112 QoQ
Shares Held
516,593
-2.9% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Sanders Capital, LLC holds $1,505,836,965 across 2 Drug Manufacturers - General names. ABBV ranks #2 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,065,628 | $1,393,483,154 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
516,593 | $112,353,811 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $112,353,811 | 516,593 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $121,593,923 | 532,163 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $126,958,707 | 548,323 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $101,931,923 | 549,143 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $114,976,823 | 548,763 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $98,183,337 | 552,523 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $109,295,898 | 553,453 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $95,167,528 | 554,848 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $101,085,166 | 555,108 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $86,032,835 | 555,158 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $82,796,569 | 555,458 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $74,789,700 | 555,108 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $93,119,572 | 584,298 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $94,181,136 | 582,768 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $78,818,580 | 587,278 | Shares | Sole | 2023-02-17 | |
| 2022-06-30 | $90,198,680 | 588,918 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $95,756,431 | 590,688 | Shares | Sole | 2022-08-24 | |
| 2021-12-31 | $80,193,087 | 592,268 | Shares | Sole | 2022-08-25 | |
| 2021-09-30 | $63,591,306 | 589,518 | Shares | Sole | 2022-08-24 | |
| 2021-06-30 | $66,684,907 | 592,018 | Shares | Sole | 2022-08-24 | |
| 2021-03-31 | $64,061,694 | 591,958 | Shares | Sole | 2022-08-24 | |
| 2020-12-31 | $63,717,604 | 594,658 | Shares | Sole | 2022-09-07 | |
| 2020-09-30 | $58,734,175 | 670,558 | Shares | Sole | 2022-09-07 | |
| 2020-06-30 | $68,777,348 | 700,523 | Shares | Sole | 2022-09-07 | |
| 2020-03-31 | $54,538,554 | 715,823 | Shares | Sole | 2022-09-07 | |
| No filing history on record for this holder in this stock. | ||||||